E Fund Management Co., Ltd. Ultragenyx Pharmaceutical Inc. Transaction History
E Fund Management Co., Ltd.
- $2.06 Billion
- Q2 2025
A detailed history of E Fund Management Co., Ltd. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 9,052 shares of RARE stock, worth $269,206. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,052
Previous 8,300
9.06%
Holding current value
$269,206
Previous $300,000
9.67%
% of portfolio
0.02%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding RARE
# of Institutions
364Shares Held
88.1MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$304 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$167 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$117 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$85.8 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$82.5 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.08B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...